Although the modalities such as ultrasonography (US) and conventional tumor markers such as α-fetoprotein-L3 (AFP-L3) and DCP are widely used and important for HCC detection in clinical scenes [7], they still do not provide an entirely satisfactory solution to detect HCC at the early stage. This evidence concerns the gene AFP and neoplasm.